ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Overall Cancer Mortality Rates Higher For Men Than Women

July 29, 2011

O’Conor Names DCCP Director, Says He’ll Push Development Of NCI’s Efforts In Epidemiology

April 28, 1978

Hammer Says President’s Science Advisory to Ask For FY 1985 Supplemental Appropriations for NCI

March 1, 1985

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010